SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-005167
Filing Date
2019-02-28
Accepted
2019-02-28 07:00:39
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K RESULTS OF OPERATIONS AND FINANCIAL CONDITION atrs-8k_20190228.htm 8-K 33041
2 EX-99.1 atrs-ex991_6.htm EX-99.1 268426
3 GRAPHIC gj3vhys3dbkk000001.jpg GRAPHIC 17898
  Complete submission text file 0001564590-19-005167.txt   327670
Mailing Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628
Business Address 100 PRINCETON SOUTH SUITE 300 EWING NJ 08628 609-359-3020
ANTARES PHARMA, INC. (Filer) CIK: 0001016169 (see all company filings)

IRS No.: 411350192 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32302 | Film No.: 19640357
SIC: 3841 Surgical & Medical Instruments & Apparatus
Assistant Director 10